These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 32381054
21. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort. Vink FJ, Lissenberg-Witte BI, Meijer CJLM, Berkhof J, van Kemenade FJ, Siebers AG, Steenbergen RDM, Bleeker MCG, Heideman DAM. Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459 [Abstract] [Full Text] [Related]
22. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, Steenbergen RD, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, Van Baal WM, Graziosi PG, Quint WG, Heideman DA, Meijer CJ. Int J Cancer; 2016 Feb 15; 138(4):992-1002. PubMed ID: 26317579 [Abstract] [Full Text] [Related]
25. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B. Int J Gynecol Cancer; 2009 Apr 15; 19(3):321-5. PubMed ID: 19407553 [Abstract] [Full Text] [Related]
26. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort. Gilham C, Sargent A, Peto J. BJOG; 2020 Jan 15; 127(1):58-68. PubMed ID: 31541495 [Abstract] [Full Text] [Related]
31. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S. Oncol Rep; 2012 Jul 15; 28(1):346-52. PubMed ID: 22484610 [Abstract] [Full Text] [Related]
34. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. Yu L, Jiang M, Qu P, Wu Z, Sun P, Xi M, Qin Y, Liu X, Liao G, Lei X, Sun L, Zhang Y, Li Z, Chen W, Qiao YL. Int J Cancer; 2018 Aug 15; 143(4):813-822. PubMed ID: 29524206 [Abstract] [Full Text] [Related]
35. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B, Zhao C, Wang Y. Oncol Rep; 2017 Apr 15; 37(4):2324-2334. PubMed ID: 28260046 [Abstract] [Full Text] [Related]
39. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or. Han L, Husaiyin S, Zhao F, Rezhake R, Niyazi M. Clin Lab; 2018 Sep 01; 64(9):1363-1371. PubMed ID: 30274003 [Abstract] [Full Text] [Related]